Clinical trials

  • TACROLIMUS for Antisynthetase syndrome-related interstitial lung disease | Interstitial lung disease
  • Fludeoxyglucose (18F) for Breast cancer|Neuroendocrine neoplasm|Lymphoma|Sarcoma
  • BILAYER ENGINEERED COLLAGEN HYDROGEL-BASED SKIN GRAFT COMPOSED OF AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS for Full-thickness skin defects
  • METFORMIN HYDROCHLORIDE for Type 1 diabetes | Vascular calcification
  • Ivabradine hydrochloride for Septic shock
  • ALLOGENEIC FAECAL MICROBIOTA, POOLED for Ulcerative colitis
  • Bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts for Deep partial-thickness burns | Full-thickness burns
  • Autologous T cells expressing CD8A and a T-cell receptor targeting MAGE-A4 for Recurrent ovarian cancer (MAGE-A4 positive) | Primary peritoneal carcinoma (MAGE-A4 positive) | Fallopian tube carcinoma (MAGE-A4 positive)
  • 2-[1-(3-{6-[(1E)-(HYDROXYIMINO)METHYL]-5-METHYL-4-OXO-7-PROPYL-3H,4H-PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL}-4-PROPOXYBENZENESULFONYL)PIPERIDIN-4-YL]ETHYL NITRATE for Scleroderma-associated digital ulcers
  • Bupivacaine hydrochloride, anhydrous for Postoperative recovery after elective minimally invasive colorectal surgery
  • DURVALUMAB for Triple-negative breast cancer|Metastatic breast cancer
  • VNA-318 for Cognitive impairment